ROSAH syndrome

Last updated
ROSAH syndrome
Autosomal dominant - en.svg
ROSAH syndrome is inherited via an autosomal dominant manner
CausesMutation in ALPK1 gene

ROSAH syndrome is a genetic disease of innate immune activation. [1] ROSAH stands for Retinal dystrophy, Optic nerve edema, Splenomegaly, Anhidrosis and Headache and the name emphasizes some, but not all, of the features that can be associated with the syndrome. [2] The disease is inherited in an autosomal dominant manner and caused by heterozygous missense mutations in the ALPK1 gene, an innate immune sensor for bacterial sugars. [3]

Contents

Signs and symptoms

While the initial descriptions of ROSAH syndrome emphasized the ocular manifestations of the disease, it is now clear that ROSAH syndrome can also present with a range of systemic features including recurrent fever, uveitis, deforming arthritis, AA amyloidosis, meningeal enhancement and premature mineralisation of the basal ganglia, substantia nigra and red nuclei on MRI. [2] [1] Additionally, clinical features not conventionally attributed to inflammation have also been reported and included short dental roots, enamel defects and decreased salivary flow. [1]

Pathophysiology

ALPK1 is a pattern recognition receptor of the innate immune system, that recognises the bacterial metabolite ADP-heptose. [3] ROSAH syndrome patients’ primary samples and in vitro assays with mutated ALPK1 constructs have shown immune activation with increased NF-κB signaling, STAT1 phosphorylation and interferon gene expression signature. [1]

Genetics

This condition is caused by mutations in the ɑ-kinase gene ( ALPK1 ) gene, most commonly changing the amino acid Threonine to Methionine at position 237 in the protein. This gene is located on the long arm of chromosome 4 (4q25). The inheritance of this condition is autosomal dominant.

Diagnosis

Currently, screening for ROSAH syndrome is initiated upon a physician's judgement. Genetic testing for ROSAH syndrome can be performed as either targeted, single-gene testing through Sanger sequencing or a multi-gene test through whole exome sequencing or whole genome sequencing. [2] [1]

Management

Some features of the disease are amenable to immunomodulatory therapy. [1] However, additional studies will be need to determine if immunomodulation can mitigate the risk of progressive vision loss in this disease.

Epidemiology

The prevalence is not known. To date, less than 70 individuals with ROSAH syndrome have been described in the medical literature. [1] [2] . ROSAH syndrome was first coined in 2019, and since then almost 70 patients have been identified from 29 unrelated families.

History

This condition was first described in 2012 prior to the discovery of the genetics and naming of the condition. [4] The genetic basis of this condition was first published in an ARVO abstract in 2013 and in a complete article in 2019. [2] In 2022, ROSAH Syndrome Foundation was established to serve patients with ROSAH syndrome by providing information and connecting them to other individuals living with ROSAH syndrome. [5]

Related Research Articles

<span class="mw-page-title-main">Alagille syndrome</span> Medical condition

Alagille syndrome (ALGS) is a genetic disorder that affects primarily the liver and the heart. Problems associated with the disorder generally become evident in infancy or early childhood. The disorder is inherited in an autosomal dominant pattern, and the estimated prevalence of Alagille syndrome is 1 in every 30,000 to 1 in every 40,000 live births. It is named after the French pediatrician Daniel Alagille, who first described the condition in 1969.

Severe congenital neutropenia (SCN), also often known as Kostmann syndrome or disease, is a group of rare disorders that affect myelopoiesis, causing a congenital form of neutropenia, usually without other physical malformations. SCN manifests in infancy with life-threatening bacterial infections. It causes severe pyogenic infections. It can be caused by autosomal dominant inheritance of the ELANE gene, autosomal recessive inheritance of the HAX1 gene. There is an increased risk of leukemia and myelodysplastic cancers.

<span class="mw-page-title-main">TNF receptor associated periodic syndrome</span> Medical condition

TNF receptor associated periodic syndrome (TRAPS) is a periodic fever syndrome associated with mutations in a receptor for the molecule tumor necrosis factor (TNF) that is inheritable in an autosomal dominant manner. Individuals with TRAPS have episodic symptoms such as recurrent high fevers, rash, abdominal pain, joint/muscle aches and puffy eyes.

<span class="mw-page-title-main">Lymphedema–distichiasis syndrome</span> Medical condition

Lymphedema–distichiasis syndrome is a medical condition associated with the FOXC2 gene. People with this hereditary condition have a double row of eyelashes, which is called distichiasis, and a risk of swollen limbs due to problems in the lymphatic system.

<span class="mw-page-title-main">Papillorenal syndrome</span> Medical condition

Papillorenal syndrome is an autosomal dominant genetic disorder marked by underdevelopment (hypoplasia) of the kidney and colobomas of the optic nerve.

<span class="mw-page-title-main">IKBKG</span> Protein-coding gene in the species Homo sapiens

NF-kappa-B essential modulator (NEMO) also known as inhibitor of nuclear factor kappa-B kinase subunit gamma (IKK-γ) is a protein that in humans is encoded by the IKBKG gene. NEMO is a subunit of the IκB kinase complex that activates NF-κB. The human gene for IKBKG is located on the chromosome band Xq28. Multiple transcript variants encoding different isoforms have been found for this gene.

<span class="mw-page-title-main">Blau syndrome</span> Medical condition

Blau syndrome is an autosomal dominant genetic inflammatory disorder which affects the skin, eyes, and joints. It is caused by a mutation in the NOD2 (CARD15) gene. Symptoms usually begin before the age of four, and the disease manifests as early onset cutaneous sarcoidosis, granulomatous arthritis, and uveitis.

MonoMAC syndrome is a rare autosomal dominant syndrome associated with: monocytopenia, B and NK cell lymphopenia; mycobacterial, viral, fungal, and bacterial opportunistic infections; and virus infection-induced cancers. The disorder often progresses to the development of myelodysplasia, myeloid leukemias, and other types of cancer. MonoMAC is a life-threatening and precancerous disorder.

<span class="mw-page-title-main">BENTA disease</span> Medical condition

BENTA disease is a rare genetic disorder of the immune system. BENTA stands for "B cell expansion with NF-κB and T cell anergy" and is caused by germline heterozygous gain-of-function mutations in the gene CARD11. This disorder is characterized by polyclonal B cell lymphocytosis with onset in infancy, splenomegaly, lymphadenopathy, mild immunodeficiency, and increased risk of lymphoma. Investigators Andrew L. Snow and Michael J. Lenardo at the National Institute of Allergy and Infectious Diseases at the U.S. National Institutes of Health first characterized BENTA disease in 2012. Dr. Snow's current laboratory at the Uniformed Services University of the Health Sciences is now actively studying this disorder.

<span class="mw-page-title-main">Caspase-8 deficiency</span> Medical condition

Caspase-8 deficiency (CEDS) is a very rare genetic disorder of the immune system. It is caused by mutations in the CASP8 gene that encodes the protein caspase-8. The disorder is characterized by splenomegaly and lymphadenopathy, in addition to recurrent sinopulmonary infections, recurrent mucocutaneous herpesvirus or other viral infections, and hypogammaglobulinemia. Investigators in the laboratory of Dr. Michael Lenardo at the National Institutes of Health described this condition in two siblings from a consanguineous family in 2002, and several more affected family members have since been identified.

<span class="mw-page-title-main">Activated PI3K delta syndrome</span> Medical condition

Activated PI3K delta syndrome (APDS) is a primary immunodeficiency disease caused by activating gain of function mutations in the PIK3CD gene. Which encodes the p110δ catalytic subunit of PI3Kδ, APDS-2 (PASLI-R1) is caused by exon-skipping mutations in PIK3R1 which encodes for the regulatory subunit p85α. APDS and APDS-2 affected individuals present with similar symptoms, which include increased susceptibility to airway infections, bronchiectasis and lymphoproliferation.

Nuclear factor-kappa B Essential Modulator (NEMO) deficiency syndrome is a rare type of primary immunodeficiency disease that has a highly variable set of symptoms and prognoses. It mainly affects the skin and immune system but has the potential to affect all parts of the body, including the lungs, urinary tract and gastrointestinal tract. It is a monogenetic disease caused by mutation in the IKBKG gene. NEMO is the modulator protein in the IKK inhibitor complex that, when activated, phosphorylates the inhibitor of the NF-κB transcription factors allowing for the translocation of transcription factors into the nucleus.

<span class="mw-page-title-main">Birk-Barel syndrome</span> Medical condition

Birk-Barel syndrome is a rare genetic disorder associated with the KCNK9 gene. Signs and symptoms include mental retardation, hypotonia, hyperactivity, and syndromic facies.

<span class="mw-page-title-main">Cole–Carpenter syndrome</span> Medical condition

Cole–Carpenter syndrome is an extremely rare autosomal recessive medical condition in humans. The condition affects less than 10 people worldwide. It is characterised by dysmorphic features and a tendency to fractures.

<span class="mw-page-title-main">CDK13-related disorder</span> Rare genetic disorder involving heart, facial and neurological features

CDK13-related disorder, also known as congenital heart defects, dysmorphic facial features and intellectual developmental disorder (CHDFIDD), is a very rare autosomal dominant genetic condition characterised by congenital heart defects, intellectual disability and characteristic facial features. Those affected typically have motor and language delays, low muscle tone and gastrointestinal dysmotility. Facial features include a wide nasal bridge, widely-spaced eyes, prominent, low-set ears, a flat nose tip and a small mouth. Less common features include congenital spinal abnormalities, hearing loss or seizures.

Autoinflammatory diseases (AIDs) are a group of rare disorders caused by dysfunction of the innate immune system. They are characterized by periodic or chronic systemic inflammation, usually without the involvement of adaptive immunity.

<span class="mw-page-title-main">Hypohidrotic ectodermal dysplasia with immune deficiency</span> Medical condition

Hypohidrotic/anhidrotic ectodermal dysplasia with immune deficiency is a rare genetic condition characterized by a combination of the features of ectodermal dysplasia alongside immunodeficiency.

<span class="mw-page-title-main">Wolfram-like syndrome</span> Medical condition

Wolfram-like syndrome is a rare autosomal dominant genetic disorder that shares some of the features shown by those affected with the autosomal recessive Wolfram syndrome. It is a type of WFS1-related disorder.

<span class="mw-page-title-main">Salt and pepper syndrome</span> Medical condition

Salt and pepper developmental regression syndrome, also known as Amish infantile epileptic syndrome or GM3 deficiency syndrome, is a rare autosomal recessive progressive neurological disorder characterized by developmental delay, severe intellectual disability, seizures, and skin pigmentation irregularities. The clinical symptoms of this condition start manifesting soon after birth, during the newborn/neo-natal stage of life.

<span class="mw-page-title-main">Spondyloenchondrodysplasia</span> Medical condition

Spondyloenchondrodysplasia is the medical term for a rare spectrum of symptoms that are inherited following an autosomal recessive inheritance pattern. Skeletal anomalies are the usual symptoms of the disorder, although its phenotypical nature is highly variable among patients with the condition, including symptoms such as muscle spasticity or thrombocytopenia purpura. It is a type of immunoosseous dysplasia.

References

  1. 1 2 3 4 5 6 7 Kozycki CT, Kodati S, Huryn L, et al. (2022). "Gain-of-function mutations in ALPK1 cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome". Annals of the Rheumatic Diseases. 81 (10): 1453–1464. doi: 10.1136/annrheumdis-2022-222629 . ISSN   0003-4967. PMC   9484401 . PMID   35868845.
  2. 1 2 3 4 5 Williams LB, Javed A, Sabri A, Morgan DJ, Huff CD, Grigg JR, Heng XT, Khng AJ, Hollink IHIM, Morrison MA, Owen LA, Anderson K, Kinard K, Greenlees R, Novacic D, Nida Sen H, Zein WM, Rodgers GM, Vitale AT, Haider NB, Hillmer AM, Ng PC, Shankaracharya, Cheng A, Zheng L, Gillies MC, van Slegtenhorst M, van Hagen PM, Missotten TOAR, Farley GL, Polo M, Malatack J, Curtin J, Martin F, Arbuckle S, Alexander SI, Chircop M, Davila S, Digre KB, Jamieson RV, DeAngelis MM (2019) ALPK1 missense pathogenic variant in five families leads to ROSAH syndrome, an ocular multisystem autosomal dominant disorder. Genet Med doi: 10.1038/s41436-019-0476-3
  3. 1 2 Zhou, Ping; She, Yang; Dong, Na; Li, Peng; He, Huabin; Borio, Alessio; Wu, Qingcui; Lu, Shan; Ding, Xiaojun; Cao, Yong; Xu, Yue; Gao, Wenqing; Dong, Mengqiu; Ding, Jingjin; Wang, Da-Cheng; Zamyatina, Alla; Shao, Feng (September 2018). "Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose". Nature. 561 (7721): 122–126. Bibcode:2018Natur.561..122Z. doi:10.1038/s41586-018-0433-3. ISSN   1476-4687. PMID   30111836. S2CID   52009376.
  4. Tantravahi, Srinivas (March 2012). "An Inherited disorder with splenomegaly, cytopenias, and vision loss". American Journal of Medical Genetics. 158A (3): 475–481. doi:10.1002/ajmg.a.34437. PMC   4242507 . PMID   22307799.
  5. "ROSAH Syndrome Foundation". rosahsyndrome.org.